GGrantIndex
Sort

25,944 grants matching neurodegeneration

Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease

$877,047
Bruce A Yankner · Harvard Medical School · T32 · FY2020 · AG

Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention

$875,885
Cheryl A London · Tufts University Boston · RC2 · FY2023 · TR

Cell autonomous and non-cell autonomous roles of the GWAS risk factor BIN1 in Alzheimer's disease neuropathology

$875,883
Gopal Thinakaran · University Of South Florida · RF1 · FY2016 · AG

Mechanisms of Somatic Mutation in Alzheimer's Disease Using Single Neuron Analysis

$875,677
Michael B Miller · Brigham And Women'S Hospital · R01 · FY2025 · AG

Clinical Investigations of Inborn Errors of Metabolism

$875,476
Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD

Disordered Cellular Cholesterol Movement, Cell Death, and Multisystem Disease

$875,449
John M. Dietschy · Ut Southwestern Medical Center · R01 · FY2010 · HL

KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology

$874,802
Andrew J Saykin · Indiana University Indianapolis · U01 · FY2025 · AG

EXERCISE EFFECTS ON SYNUCLEIN AGGREGATION, NEUROINFLAMMATION, AND NEURODEGENERATION.

$873,885
Northeast Ohio Medical University · · FY2019 · Defense Health Agency

Transdiagnostic memory, mood and motor circuits in Alzheimer's and neurodegenerative disease

$873,295
Michael D Fox · Brigham And Women'S Hospital · R56 · FY2021 · AG

Preoperative Occult Neurodegeneration and Postoperative Delirium

$873,104
Gregory Crosby · Brigham And Women'S Hospital · R01 · FY2025 · AG

Systems biology of HIV, methamphetamine and antiretrovirals interactions

$872,331
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2019 · DA

Pathogenesis of Neurological Disability in Primary Diseases of Myelin

$871,750
Bruce D Trapp · Cleveland Clinic Lerner Com-Cwru · R35 · FY2018 · NS

Pathogenesis of Neurological Disability in Primary Diseases of Myelin

$871,750
Bruce D Trapp · Cleveland Clinic Lerner Com-Cwru · R35 · FY2019 · NS

Pathogenesis of Neurological Disability in Primary Diseases of Myelin

$871,750
Bruce D Trapp · Cleveland Clinic Lerner Com-Cwru · R35 · FY2020 · NS

Pathogenesis of Neurological Disability in Primary Diseases of Myelin

$871,750
Bruce D Trapp · Cleveland Clinic Lerner Com-Cwru · R35 · FY2023 · NS

Pathogenesis of Neurological Disability in Primary Diseases of Myelin

$871,750
Bruce D Trapp · Cleveland Clinic Lerner Com-Cwru · R35 · FY2022 · NS

Pathogenesis of Neurological Disability in Primary Diseases of Myelin

$871,750
Bruce D Trapp · Cleveland Clinic Lerner Com-Cwru · R35 · FY2021 · NS

Pathogenesis of Neurological Disability in Primary Diseases of Myelin

$871,750
Bruce D Trapp · Cleveland Clinic Lerner Com-Cwru · R35 · FY2017 · NS

Regulation of diverse microglial phenotypes in neurodegeneration

$871,419
Suman Jayadev · University Of Washington · R56 · FY2023 · AG

Imaging intracerebral and systemic T cell immunity in patients with Alzheimer's disease using 18F-F-AraG

$871,261
Jelena Levi · Cellsight Technologies, Inc. · R44 · FY2025 · AG

Microbial Impact on NeuroDegeneration in Alzheimer's Dementia: MIND-AD

$871,255
Adam Peter Spira · Johns Hopkins University · R01 · FY2022 · AG

Role of transposon dysregulation in Alzheimer and aging brains revealed by single-cell genomic and transcriptomic analysis

$871,185
Eunjung Alice Lee · Boston Children'S Hospital · R01 · FY2023 · AG

Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids

$871,147
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2022 · DA

Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids

$871,147
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2021 · DA

Treating mild cognitive impairment with transcranial direct current stimulation

$870,064
Benjamin Michael Hampstead · University Of Michigan At Ann Arbor · R01 · FY2018 · AG